To comprehensively understand these four lncRNAs (LINC01224, CASC9, LINC00346, and TRPM2-AS) and seven target mRNAs (CCNF, PKMYT1, GCH1, TK1, PSAT1, ADAM33, and DDX11), we performed genome instability, immune, cancer stemness, and drug sensitivity analysis. This evidence concerns the gene PSAT1 and cancer.